No Data
No Data
Hologic (HOLX) Moves Up 2% in a Week: Time to Consider Buying?
Hologic Is Maintained at In-Line by Evercore ISI Group
Hologic Is Maintained at In-Line by Evercore ISI Group
Evercore Maintains Hologic(HOLX.US) With Hold Rating, Raises Target Price to $76
Evercore analyst Vijay Kumar maintains $Hologic(HOLX.US)$ with a hold rating, and adjusts the target price from $73 to $76.According to TipRanks data, the analyst has a success rate of 47.4% and a tot
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2024 on Monday, July 29, 2024
Hologic, Inc. (NASDAQ:HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2024 on Monday, July 29, after the market closes. In conjunction with the release,
Evercore ISI Adjusts Price Target on Hologic to $76 From $78, Maintains In-line Rating
Hologic (HOLX) has an average outperform rating and a price target range of $70 to $95, according to analysts polled by Capital IQ.
Peering Into Hologic's Recent Short Interest
Hologic's (NYSE:HOLX) short percent of float has fallen 8.59% since its last report. The company recently reported that it has 4.64 million shares sold short, which is 2.98% of all regular shares that
No Data